The inventor of the groundbreaking Crispr gene-editing technology is skeptical about artificial intelligence replacing human ...

By Deena Beasley SAN DIEGO, June 22 (Reuters) - China, which now conducts more clinical drug trials than the U.S., still lags ...

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...

The United States's dominance in biotech innovation is crucial to our national interests and global security. In recent years, China has quickly become a powerhouse, bolstered by its biotech-friendly ...

In interviews as well as a panel at BIO’s annual meeting, investors and life sciences bankers predicted an acceleration in ...

A mgen plans to invest more than $600 million in a new, state-of-the-art center for science and innovation at its global headquarters in Thousand Oaks, California. The center is designed to bring ...

The Clinical Trials on Alzheimer's Disease (CTAD) conference and the Alzheimer's Drug Discovery Foundation (ADDF) today ...

SYDNEY--(BUSINESS WIRE)--Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, is featured in The Next Frontier, a global branded series ...

SAN FRANCISCO--(BUSINESS WIRE)--As Demy-Colton and EBD Group’s Biotech Showcase™ concluded its 18 th year, the event continued to distinguish itself as a leading hub for early-stage biotechnology ...

China and the U.S. are in a race for preeminence in biotechnology. The U.S. is still dominant in biology and life sciences research, but China is catching up fast. At the same time, Congress and the ...

Karnataka is developing a dedicated support framework for its biotechnology sector, encompassing funding, mentoring, and ...

Michael Schultz is director of venture operations at Portal Innovations, where he is always looking for innovations that could revolutionize the life sciences. "We work with many startups, and all of ...